Vein & Skin Treatment Center is categorized under Primary Care Centers in El Paso, TX and active since 2012.
Vein & Skin Treatment Center was established in 2012, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Primary Care Centers business, which does work in the B2C market, and is classified as a Primary Care Centers, under code number 6214930 by the NAICS.
If you are seeking more information, feel free to contact Paul D Cooney at the company’s single location by writing to 7812 Gateway Boulevard East, El Paso, Texas TX 79915 or by phoning (915) 633-1893. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Vein & Skin Treatment Center |
| Contact Person: | Paul D Cooney |
| Address: | 7812 Gateway Boulevard East, El Paso, Texas 79915 |
| Phone Number: | (915) 633-1893 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2012 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Primary Care Centers |
| SIC Code: | 8011 |
| NAICS Code: | 6214930 |
| Share This Business: |
Vein & Skin Treatment Center was started in 2012 to provide professional Primary Care Centers under the SIC code 8011 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Paul D Cooney for inquiries that concern Vein & Skin Treatment Center by calling the company number (915) 633-1893, as your correspondence is most welcome. Additionally, the physical location of the single location of Vein & Skin Treatment Center can be found at the coordinates 31.75813,-106.35496 as well as the street address 7812 Gateway Boulevard East in El Paso, Texas 79915.
For its online presence, you may visit Vein & Skin Treatment Center’s website at and engage with its social media outlets through on Twitter and on Facebook.